who have undergone a transplant. An epidemiologic study showed that in renal transplanted patients, the incidence of Kaposi' s sarcoma was 400 to 500 times higher than in controls of the same ethnic origin. We report a case of Kaposi' s sarcoma involving the lung and skin after immunosuppressive therapy in a patient with renal transplant. A plain chest radiograph showed diffusely increased interstitial opacity with multiple, ill-defined small nodules in both lung fields. HRCT revealed multiple small nodules, predominantly in the peribronchovascular regions, and ill-defined areas of ground-glass opacity and consolidation in both lungs.
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Kaposi' s sarcoma is the most common neoplasm affecting patients with acquired immunodeficiency syndrome (AIDS) and occurs in 10 -20 % of all AIDS patients; it may also occur in organ transplanted recipient who undergo prolonged or intensive immunosuppressive therapy(l). The radiologic manifestations of AIDSrelated pulmonary Kaposi' S sarcoma have been reported(2 -4). Though high-resolution computed tomography (HRCT) findings of pulmonary Kaposi' s sar coma after renal transplantation.
We report chest radiographic and high resolution computed tomographic findings in a case of Kaposi's sarcoma involving the lung and skin after immunosuppressive therapy in a renal transplant patient. ' 
Case Report
A 31-year-old man was admitted to hospital with a two-week history of cough, dyspnea, mild fever. hemoptysis, and the presence of numerous skin lesions on the legs. Five years ago, a kidney transplant had been performed, and he had been treated with prednisone (30mg daily) and cyclosporin A(maintenence dose, 200mg daily). Because of chronic rejection, OKT3 (Muromonab CD 3, 5mg daily) had recently been administrated. Blood chemistry showed that blood urea nitrogen and creatinine levels were 29.5mg/dl and 2.5mg/dl respectively. Serologic tests for human immunodeficiency virus and cytomegalovirus were negative. On physical examination, a coarse breathing sound was heard, with rhonchus and rale throughout the chest. Multiple small nodules and plaques, some ulcerated and purplish were found on both legs. A plain chest radiograph showed diffusely increased interstitial opacity with multiple, ill-defined small nodules in both lung fields (Fig. 1A) .
HRCT demonstrated multiple small nodules, predominantly in the peribronchovascular and subpleural regions, and ill-defined areas of ground-glass opacity and consolidation in both lungs (Fig. lB & C) . Neither definite pleural effusion nor mediastinal lymph node enlargement was seen, and bronchoscopy revealed no endobronchiallesion.
Specimens of open lung biopsy showed multiple rubbery nodules up to 3mm in size, along the bronchovascular bundles as well as foci of multifocal intraalveolar hemorrhagic. Microscopically several relatively well demarcated solid nodules were seen in the lung tissue. They showed the typical features of Kaposi' s sarcoma, including spindle cell proliferation with endothelial-lined vascular slits and many extrav-A asated erythrocytes (Fig. lD) . In situ hybridization for cytomegalovirus and Ebstein-barr virus was negative. But skin biopsy also indicated early stage Kaposi's sarcoma.
Discussion
Kaposi' s sarcoma is a multifocal tumor characterized by proliferation of endothelial and spindle cells. Its nature is disputed, it might not be a true neoplasm but rather a proliferative reaction to abnormal growth factors(S). There are four types: the classic sporadic Kaposi' s sarcoma accounts for more than 3 % of neoplasms occurring in transplant patients and an epidemiologic study showed that in renal transplant patients, its incidence was 400 to SOO times higher than in controls of the same ethnic origin(7). Penn (1) enumerated several factors which might induce tumors after organ transplant; these were disturbance of immunity, oncogenic viruses, the oncogenic effect of immunosuppressive agents, variations in the individual' s susceptibility, and chronic antigen stimulation. Pulmonary Kaposi' s sarcoma, which occurs in 18 -47 % of patients with known cutaneous Kaposi's sarcoma, affects the tracheobronchial tree, lung parenchyma or pleura individually or in combination (8 -10) . The presence of cutaneous Kaposi' s sarcoma is an important pointer to the possibility oflung involvement, and pulmonary Kaposi' s sarcoma is rare in the absence of cutaneous Kaposi' s sarcoma (8) . Another clinical pointer is the occurrence of hemoptysis. In volvement ofthe tracheobronchial tree in Kaposi' s sarcoma is relatively frequent, and the lesions are highly vascular ( 9) Grossly and microscopically, the lesions of Kaposi's sarcoma are hemorrhagic nodules found along the lymphatic routes (9) . Mural infiltration of vessels and airways is common . Histologically, there is a proliferation of spindle cells with intercellular clefts, extravasation of red blood cells, scattered hemosiderin, cyto plasmic eosinophilic bodies, ectasia of surrounding vascular spaces, and prominent plasma cells in surrounding tissues. Early cases may manifest as peribronchial or perivascular fibrous tissue thickened with increased spindle cells, hemosiderin, and plasma cells (9 ) Chest radiographs typically show bilateral and diffuse abnormalities characterized by the presence ofinterstitial opacities that are predominantly peribronchovascular, poorly defined nodules which can be several centimeters in diameter, and ill-defined areas of consolidation. Pleural involvement is common and effusions are usually bilateral and may be large. In some series, hilar and mediastinal adenopathy has been detected in 2S to 60 % of cases(2 -4). Naidich and associates (2) suggested that CT scanning, while not defi nitive, may be sufficiently characterist 까 m ular septal thickening, pleural effusion, and lymphadenopathy in AIDS. An interesting finding is the relatively high CT attenuation of Kaposi' s nodules on dynamic scans following a bolus injection ofintravenous contrast medium (3) . This high attenuation is thought to ref1ect the pronounced hypervascularity ofKaposi's sarcoma and was found in 80 % of cases in this series(3). Khalil reported that scattered ground-glass opacity was found in three of S3 cases ; in two cases it was associated with intra-alveolar hemorrhage(4). In our case, the patient presented with hemoptysis and HRCT revealed multifocal ground-glass opacity which pathologically, correlated with intra-alveolar hemorrhage.
IfKaposi' s sarcoma develops, it usually becomes evident 14 -34 months after a transplant. The behavior of the tumor is different in transplant patients than in those suffering from Kaposi' s sarcoma of the classic type or from AIDS patients. The level of immune deficiency appears to play a role (10) . In patients undergoing immunosuppressive therapy, lymph node involvement is rare, visceral disease is less common, and fatalities resulting from Kaposi' s sarcoma are less frequent. In our case, the pulmonary nodules were smaller, mainly less than 1 cm in diameter, and relatively well defined, as compared to AIDS related Kaposi' s sarcoma. Mediastinal lymph node involvement and pleural effusion were not associated. The main finding in our case was ground-glass opacity representing intra-alveolar hemorrhage.
Although HRCT findings are not pathognomonic, HRCT findings of peribronchovascular and subpleural lesion, and combined skin lesion, are helpful diagnostic indicators of Kaposi' s sarcoma in an immunosuppressed patient.
